CCC4 Therapeutics, Inc. CCCC · NASDAQ
$3.38 +2.27% (+$0.08)
- Market cap
- $406.0M
- Enterprise value
- $384.2M
- P/E
- -
- Forward P/E
- -
- PEG
- -
- P/S
- 11.6x
- P/FCF
- -
- EV/EBITDA
- -
- ROIC
- -35.2%
- Gross margin
- 94.9%
- Net margin
- -289.4%
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- -
- Beta
- 3.08
- Free float
- 76.8%
About the company
C4 Therapeutics, Inc. (CCCC) is a biotechnology company focused on developing novel therapeutics based on protein degradation technology. Their platform enables the creation of small molecules that bind to target proteins and induce their selective degradation. This innovative therapeutic strategy has the potential to treat a wide range of diseases, including cancer and neurodegenerative disorders. C4 Therapeutics collaborates with major pharmaceutical companies to develop and commercialize new drug candidates. Their goal is to bring innovative treatment options to patients with various diseases. Shares of C4 Therapeutics, Inc. (CCCC) may be an attractive investment opportunity for investors interested in advanced therapeutic technologies and the biotechnology sector.
Sector
Healthcare
Industry
Biotechnology
CEO
Andrew J. Hirsch
Employees
104
Headquarters
Watertown
Valuation
Is today's price reasonable?
Growth and estimates
Is it growing, and what comes next?
- What speaks for it: It beat profit estimates 7 times in the last 8 quarters.
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
- What to watch: The company made a loss over the last 12 months.
Financial health
Can it carry its debt?
- What speaks for it: It holds more cash than debt: $78.6M against $56.9M.
- What to watch: It passes only 3 of the 9 points of the Piotroski financial health test.
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number